Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) and hyperinsulinemia are associated closely with endometrial carcinoma risk, although the molecular mechanism remains unclear. Insulin receptor isoformA expression is upregulated in many cancer cells and tissues, which su...
Main Authors: | Chun-Fang Wang, Guo Zhang, Li-Jun Zhao, Wen-Juan Qi, Xiao-Ping Li, Jian-Liu Wang, Li-Hui Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3737217?pdf=render |
Similar Items
-
Dicer1 dysfunction promotes stemness and aggression in endometrial carcinoma
by: Xiao-Jun Wang, et al.
Published: (2017-04-01) -
Insulin Receptor Isoforms in Cancer
by: Veronica Vella, et al.
Published: (2018-11-01) -
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
by: Lin Q, et al.
Published: (2021-02-01) -
Engineering of insulin receptor isoform-selective insulin analogues.
by: Tine Glendorf, et al.
Published: (2011-01-01) -
Epidermal growth factor receptor (EGFR) overexpression in endometrial carcinoma: association with histopathologic parameters
by: Atif Ali Hashmi, et al.
Published: (2019-03-01)